TrialBreast cancer research and treatment2019

Strong impact of MammaPrint and BluePrint on treatment decisions in luminal early breast cancer: results of the WSG-PRIMe study.

R Wuerstlein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.